Skip to main content
Top

Journal of Cancer Research and Clinical Oncology

Issue 7/2000

Content (9 Articles)

REVIEW

Pathology of small-cell lung cancer

K. Junker, Th. Wiethege, K.-M. Müller

REVIEW

Geriatric assessment in the elderly cancer patient

R. Harlacher, I. Füsgen

ORIGINAL PAPER

Expression of blood group antigens A, B and H in carcinoma tissue correlates with a poor prognosis for colorectal cancer patients

Tohru Nakagoe, Atsushi Nanashima, Terumitsu Sawai, Takashi Tuji, Masayuki Ohbatake, Masaaki Jibiki, Hiroyuki Yamaguchi, Toru Yasutake, Hiroyoshi Ayabe, Tatsuki Matuo, Yutaka Tagawa

ORIGINAL PAPER

Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene

M. Flasshove, W. Bardenheuer, A. Schneider, G. Hirsch, P. Bach, C. Bury, T. Moritz, S. Seeber, B. Opalka

ORIGINAL PAPER

Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array

Lu Xie, Liangguo Xu, Zhiwei He, Wen Zhou, Lei Wang, Ling Zhang, Ke Lan, Caiping Ren, Weidong Liu, Kaitai Yao

ORIGINAL PAPER

Malignancies in patients with insulin-treated diabetes mellitus

Roland Kath, Ralf Schiel, Ulrich Alfons Müller, Klaus Höffken

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine